Yu Liang Selected Research

Malaria

2/2022	Genome-Wide Identification, Characterization and Expression Analysis of Lipoxygenase Gene Family in Artemisia annua L.
1/2022	Allele-aware chromosome-level genome assembly of Artemisia annua reveals the correlation between ADS expansion and artemisinin yield.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Liang Research Topics

Disease

72	Neoplasms (Cancer) 07/2022 - 12/2002
16	Infections 07/2022 - 09/2003
11	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2014
11	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2018
10	Reperfusion Injury 01/2022 - 12/2013
9	Inflammation (Inflammations) 06/2022 - 01/2004
9	Hepatocellular Carcinoma (Hepatoma) 09/2021 - 09/2008
8	Ischemia 06/2022 - 12/2013
8	Carcinogenesis 01/2022 - 09/2008
7	Brain Ischemia (Cerebral Ischemia) 01/2022 - 12/2011
7	Carcinoma (Carcinomatosis) 03/2020 - 03/2012
6	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2012
5	Alzheimer Disease (Alzheimer's Disease) 06/2021 - 01/2004
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021 - 01/2016
5	Breast Neoplasms (Breast Cancer) 04/2020 - 01/2012
4	Hypoxia (Hypoxemia) 01/2022 - 07/2010
4	Graves Ophthalmopathy 01/2021 - 01/2020
4	Spinal Cord Ischemia 01/2019 - 01/2017
4	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2019 - 06/2002
4	Atherosclerosis 12/2018 - 08/2004
4	Glioma (Gliomas) 08/2014 - 07/2005
4	Pain (Aches) 01/2014 - 07/2009
3	Anemia 04/2022 - 10/2019
3	Diarrhea 02/2022 - 10/2019
3	Esophageal Squamous Cell Carcinoma 01/2022 - 06/2014
3	Brain Injuries (Brain Injury) 01/2022 - 12/2012
3	Hypertension (High Blood Pressure) 01/2022 - 04/2004
3	Esophageal Neoplasms (Esophageal Cancer) 12/2021 - 06/2014
3	Wounds and Injuries (Trauma) 07/2021 - 10/2013
3	Fibrosis (Cirrhosis) 01/2021 - 01/2015
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 05/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2020 - 10/2011
3	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 12/2011
3	Colonic Neoplasms (Colon Cancer) 07/2019 - 05/2016
3	Schistosomiasis (Bilharziasis) 11/2017 - 11/2004
3	Lung Neoplasms (Lung Cancer) 01/2017 - 12/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2008 - 02/2005
2	Ischemic Stroke 06/2022 - 12/2020
2	Malaria 02/2022 - 01/2022
2	Colitis 02/2022 - 04/2014
2	Insulin Resistance 01/2022 - 01/2003
2	Liver Diseases (Liver Disease) 01/2022 - 12/2012
2	Ganglion Cysts (Ganglion) 10/2021 - 02/2013
2	Parkinson Disease (Parkinson's Disease) 08/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2002
15	MicroRNAs (MicroRNA)IBA 07/2022 - 03/2007
14	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2003
12	Pharmaceutical PreparationsIBA 02/2022 - 11/2009
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2011
10	Messenger RNA (mRNA)IBA 12/2021 - 02/2004
9	EnzymesIBA 08/2020 - 11/2009
8	Glucose (Dextrose)FDA LinkGeneric 07/2022 - 01/2004
8	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 02/2005
7	6-methyladenineIBA 01/2022 - 11/2018
7	VaccinesIBA 12/2021 - 06/2002
6	ChromatinIBA 01/2022 - 11/2009
6	Long Noncoding RNAIBA 01/2022 - 11/2018
6	MethyltransferasesIBA 01/2022 - 11/2018
6	Competitive Endogenous RNAIBA 10/2020 - 11/2018
5	CytokinesIBA 06/2022 - 01/2015
5	AntioxidantsIBA 01/2022 - 12/2011
5	salicylhydroxamic acid (SHAM)IBA 01/2017 - 12/2011
4	Neuroprotective AgentsIBA 06/2022 - 09/2015
4	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2021 - 11/2008
4	Tyrosine Kinase InhibitorsIBA 09/2020 - 01/2019
4	Transcription Factors (Transcription Factor)IBA 10/2018 - 07/2010
3	Metformin (Glucophage)FDA LinkGeneric 07/2022 - 11/2020
3	CalciumIBA 04/2022 - 01/2017
3	Phosphorus (Red Phosphorus)IBA 04/2022 - 02/2015
3	Circular RNAIBA 01/2022 - 01/2020
3	CreatinineIBA 01/2022 - 04/2012
3	Uric Acid (Urate)IBA 01/2022 - 04/2013
3	InterleukinsIBA 01/2021 - 01/2014
3	Troleandomycin (TAO)FDA Link 01/2021 - 01/2020
3	ErbB Receptors (EGF Receptor)IBA 04/2020 - 04/2006
3	LipidsIBA 01/2020 - 12/2011
3	Peptides (Polypeptides)IBA 10/2019 - 11/2008
3	Indicators and Reagents (Reagents)IBA 01/2019 - 05/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2017 - 12/2011
3	Sevoflurane (Ultane)FDA LinkGeneric 09/2015 - 12/2011
3	AntigensIBA 01/2015 - 11/2004
3	UromodulinIBA 12/2013 - 04/2012
3	Histones (Histone)IBA 02/2013 - 11/2009
3	Liver X ReceptorsIBA 04/2012 - 02/2004
3	Viral ProteinsIBA 04/2006 - 12/2003
2	artemisinin (artemisinine)IBA 02/2022 - 01/2022
2	Hemoglobins (Hemoglobin)IBA 01/2022 - 06/2010
2	Urea (Carbamide)FDA LinkGeneric 01/2022 - 05/2014
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2022
2	NitrogenIBA 01/2022 - 05/2014
2	Antiviral Agents (Antivirals)IBA 10/2021 - 02/2013
2	Sirolimus (Rapamycin)FDA Link 08/2021 - 08/2020
2	SynucleinsIBA 08/2021 - 01/2016

Therapy/Procedure

23	Therapeutics 02/2022 - 09/2003
9	Drug Therapy (Chemotherapy) 04/2020 - 09/2003
4	Ischemic Postconditioning 06/2022 - 12/2020
4	Radiotherapy 01/2022 - 01/2008
3	Lasers (Laser) 01/2022 - 02/2020
2	Peritoneal Dialysis 04/2022 - 01/2022
2	Chemoradiotherapy 01/2022 - 01/2021